translate01.jpg 会員ログイン japhmedパンフレット(pdf) SMDプログラム 日本製薬医学会教育コース MSL制度認定事業
製薬医学セミナー
年次大会(総会)
部会のご案内
製薬医学認定医制度
提言



ssl

ホーム > What's New > 【ご案内】17th International Conference on Pharmaceutical Medicine(2013/3/20-3/21)

【ご案内】17th International Conference on Pharmaceutical Medicine(2013/3/20-3/21)

JAPhMedの上部団体であるIFAPP(国際製薬医学医師連合会:International Federation of Associations of Pharmaceutical Physicians)の主催により、
17th International Conference on Pharmaceutical Medicineが2014/3/20-2014/3/21にベルリンで開催されます。

皆様のご参加をお待ち申し上げます。

詳しくはホームページ(http://www.icpm2014.com/)ならびに以下をご覧ください。

お申し込み、お問い合わせにつきましては主催者にご連絡ください。

====================================================
2nd ANNOUNCEMENT & INVITATION

17th International Conference on Pharmaceutical Medicine
30. Jahreskongress der DGPharMed
- Berlin, Germany, March 20th - 21st, 2014 -

SMART DEVELOPMENT FOR BETTER DRUGS [http://www.icpm2014.com/]

Dear Colleague
Dear Clinical Research and Pharmaceutical Medicine Professional

We warmly invite you to attend the 17th International Conference on Pharmaceutical Medicine (ICPM 2014). It is an international forum for pharmaceutical physicians, pharmaceutical medicine professionals and clinical research experts world-wide who are involved in the discovery, development, evaluation, registration, monitoring and marketing of medicines. ICPM 2014 is a unique opportunity for all participants to listen and interact with opinion leaders and stakeholders from academia, governments, pharmaceutical companies, contract research organizations (CROs), and non-governmental organizations (NGOs) from all over the world in a neutral environment and a friendly forum.

2nd EXCERPT from the SCIENTIFIC PROGRAM
"Global Scope Regulations in Pharmacovigilance"
Thursday, 20th March 2014 - 1:30 - 3:00 pm

Pharmacovigilance (PV) issues are a prominent part of the ICPM 2014 program, including "A glance at the Global Pharmacovigilance Landscape - some practical aspects", "PV in EU and US - where are the main differences?", "Quantitative and qualitative benefit risk evaluation: A new approach to measure risk", and "Risk management and risk minimization: How to monitor success?"

The overall goal of all PV activities worldwide is risk minimization in relation to the use of medicines. The regulatory framework for risk minimization is complex and might differ from country to country, and in case of a serious adverse event PV comes to the fore of public attention. Therefore a proactive approach is even more required and any serious adverse event of a particular medicine might increasingly be considered to be a failure not only of the medicine but also of the PV system of the particular authorization holder.

To successfully cope with all this it requires highly qualified professionals who constantly increase their expertise by sharing knowledge and experience - in this regard ICPM 2014 offers an excellent opportunity.

2nd GLANCE at BERLIN/GERMANY - "Berlin - a splendid cultural city"

Joining ICPM 2014 offers you the chance to explore the splendid cultural city Berlin with about 170 museums of art, science and history. Enjoy visiting the famous bust of the ancient Egyptian queen Nefertiti or the Pergamon altar. Come and see the collection of 20th century European painting and sculpture in the New National Gallery, also named the "temple of light and glass" designed by the eminent architect Ludwig Mies van der Rohe. Or feel the particular atmosphere at the "Checkpoint Charlie" where you learn the history of the Berlin Wall and the stories of those affected by it. And - last but not least - you also might devote attention to the Memorial to the Murdered Jews of Europe, which is close to the Brandenburg Gate.

Whatever you are interested in - "Berlin in Brief" [http://www.berlin.de/en] provides you more information.

Addendum

ICPM 2014 is jointly organized by the 'International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine' (IFAPP [http://www.ifapp.org]) and the German Society of Pharmaceutical Medicine (‚Deutsche Gesellschaft für Pharmazeutische Medizin e.V.' - DGPharMed [http://www.dgpharmed.de]). IFAPP and DGPharMed are independent non-profit organizations.

As colleagues in clinical research and pharmaceutical medicine we kindly ask you for your support: Please consider to share this information by forwarding this email to your colleagues or to any person or party or any other channel inside and outside your organization which might be interested in these ICPM 2014 topic.

As a company and service provider in clinical research and pharmaceutical medicine - please consider to present your services and business at a booth at the ICPM 2014 exhibition. For more information please contact the event organization, Katrin Schröder, at schroeder@prime-con.de

As a media representative please share this information with your readers, viewers or listeners. For this purpose you are free to use the attached PDF "[http://japhmed.jp/ICPM2014/ICPM-2014-Flyer.pdf]" or parts of it in any way. Media representatives who wish to attend ICPM 2014 for reporting should call for accreditation without charge by email to the address indicated below.

For the program, registration and other issues please visit the ICPM 2014 Website at [http://www.icpm2014.com]

 

With kind regards

Yil-Seob Lee, MD, PhD, South Korea, IFAPP President, ICPM 2014 Organizer
Axel Mescheder, MD, PhD, Germany, DGPharMed President, ICPM 2014 Organizer

Kurt Bestehorn, MD, PhD, Germany, for the ICPM 2014 Organizers, Head of the ICPM 2014 Public Relation Team
DGPharMed
Olschewskibogen 7
80935 Munich - GERMANY
email: info@dgpharmed.de

Eckhard Boettcher-Buehler, Germany, for the ICPM 2014 Public Relation Team
Science Writer | Intelligible Science | Medical Communication
Member of the German 'Working Party of Medical Publicist - Club of Science Journalists'
www.boebue.de
phone: +49 172 - 836 20 22
email: presse@boebue.de



メーリングリストバナー
入会案内バナー



Google
Web JAPhMed
サイト内検索


cimic製薬オンライン
記事・プレスリリース
JAPhMedニュース